PPARA and metabolic dysfunction-associated steatotic liver disease: Also, de novo hepatic lipogenesis (DNL) seems to be upregulated in most subjects with NAFLD, which relates to inactivation of peroxisome proliferator-activated receptor-alpha (PGC1-α) and upregulation of SREBP1c (82, 85–87).